With the raise of artificial intelligence, expectations for therapy success prediction in rheumatology have increased. Recent studies show promising results, but low data-quality, incomplete information and the lack of lifestyle data remain an issue. Mobile apps might provide a solution to improve qualitative health data collection.
The digital therapeutic Midaia consists of a patient app and doctor web application. By using an intelligent chat service, patient health data is collected to predict personalized therapy plans, accelerate behavioral change and support doctors in their decision-making. Midaia will accelerate the collection of high-quality and complete clinical, laboratory and lifestyle data across large patient populations. This will build the basis for flare predictions and improved treatment decision-making in rheumatology.
Christine Peine is the Co-Founder of Midaia, a digital health company focusing on solutions for inflammatory-rheumatic diseases. She has been working in the healthcare sector for more than 5 years. Christine is leading the product development at Midaia.
Felix Lang is the Co-Founder of Midaia, a digital health company focusing on solutions for inflammatory-rheumatic diseases. He is responsible for business development and clinical partnerships.
About the company:
Midaia is a digital health company providing therapy support for rheumatic disease patients and caregivers. Using an intelligent chat service, patient health data is collected to predict personalized therapy plans, accelerate behavioural change and support doctors in making medical treatment decisions.
If you like to watch the recorded lecture please sign in as a member or go to memberarea!